{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:34:02Z","timestamp":1790649242652,"version":"4.1.0"},"reference-count":26,"publisher":"American Association for Cancer Research (AACR)","issue":"7","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Autophagy inhibition is a potential therapeutic strategy in cancer, but it is unknown which tumors will benefit. The BRAFV600E mutation has been identified as important in pediatric central nervous system (CNS) tumors and is known to affect autophagy in other tumor types. We evaluated CNS tumor cells with BRAFV600E and found that mutant (but not wild-type) cells display high rates of induced autophagy, are sensitive to pharmacologic and genetic autophagy inhibition, and display synergy when the clinically used autophagy inhibitor chloroquine was combined with the RAF inhibitor vemurafenib or standard chemotherapeutics. Importantly, we also demonstrate that chloroquine can improve vemurafenib sensitivity in a resistant ex vivo primary culture and provide the first demonstration in a patient harboring the V600E mutation treated with vemurafenib that the addition of chloroquine can improve clinical outcomes. These findings suggest that CNS tumors with BRAFV600E are autophagy-dependent and should be targeted with autophagy inhibition in combination with other therapeutic strategies.<\/jats:p>\n                  <jats:p>Significance: Autophagy inhibition may improve cancer therapy, but it is unclear which tumors will benefit. We found that BRAF mutations cause brain tumor cells to depend on autophagy and display selective chemosensitization with autophagy inhibition. We present a pediatric case in which deliberate autophagy inhibition halted tumor growth and overcame acquired BRAF-inhibition resistance. Cancer Discov; 4(7); 773\u201380. \u00a92014 AACR.<\/jats:p>\n                  <jats:p>This article is highlighted in the In This Issue feature, p. 745<\/jats:p>","DOI":"10.1158\/2159-8290.cd-14-0049","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T00:53:17Z","timestamp":1400028797000},"page":"773-780","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":218,"title":["Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors"],"prefix":"10.1158","volume":"4","author":[{"given":"Jean M. Mulcahy","family":"Levy","sequence":"first","affiliation":[{"name":"Authors' Affiliations: Departments of 1Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua C.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Griesinger","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Amani","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Donson","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane K.","family":"Birks","sequence":"additional","affiliation":[{"name":"2Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Morgan","sequence":"additional","affiliation":[{"name":"3Pharmacology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Mirsky","sequence":"additional","affiliation":[{"name":"4Radiology, University of Colorado Denver, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Handler","sequence":"additional","affiliation":[{"name":"2Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas K.","family":"Foreman","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Thorburn","sequence":"additional","affiliation":[{"name":"3Pharmacology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2014,7,6]]},"reference":[{"key":"2022060623485312800_bib1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"2022060623485312800_bib2","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1158\/1078-0432.CCR-11-1456","article-title":"Targeted therapy for BRAFV600E malignant astrocytoma","volume":"17","author":"Nicolaides","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2022060623485312800_bib3","doi-asserted-by":"crossref","first-page":"e17948","DOI":"10.1371\/journal.pone.0017948","article-title":"BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications","volume":"6","author":"Dias-Santagata","year":"2011","journal-title":"PLoS ONE"},{"key":"2022060623485312800_bib4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/neuonc\/noq007","article-title":"Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas","volume":"12","author":"Dougherty","year":"2010","journal-title":"Neuro Oncol"},{"key":"2022060623485312800_bib5","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1097\/PAS.0b013e3182382a3f","article-title":"Atypical teratoid\/rhabdoid tumor arising in a ganglioglioma: genetic characterization","volume":"35","author":"Kleinschmidt-DeMasters","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"2022060623485312800_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","article-title":"Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma","volume":"121","author":"Schindler","year":"2011","journal-title":"Acta Neuropathol"},{"key":"2022060623485312800_bib7","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"2022060623485312800_bib8","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/JTO.0b013e3182629903","article-title":"A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib","volume":"7","author":"Gautschi","year":"2012","journal-title":"J Thorac Oncol"},{"key":"2022060623485312800_bib9","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMc1202124","article-title":"BRAF inhibition in refractory hairy-cell leukemia","volume":"366","author":"Dietrich","year":"2012","journal-title":"N Engl J Med"},{"key":"2022060623485312800_bib10","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1158\/2159-8290.CD-13-0297","article-title":"Targeting BRAF in multiple myeloma","volume":"3","author":"O'Donnell","year":"2013","journal-title":"Cancer Discov"},{"key":"2022060623485312800_bib11","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1200\/JCO.2012.44.1568","article-title":"Brainstem ganglioglioma successfully treated with vemurafenib","volume":"31","author":"Rush","year":"2013","journal-title":"J Clin Oncol"},{"key":"2022060623485312800_bib12","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/jid.2010.26","article-title":"Induction of autophagy and inhibition of melanoma growth in vitro and in vivo by hyperactivation of oncogenic BRAF","volume":"130","author":"Maddodi","year":"2010","journal-title":"J Invest Dermatol"},{"key":"2022060623485312800_bib13","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1158\/2159-8290.CD-13-0397","article-title":"Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors","volume":"3","author":"Strohecker","year":"2013","journal-title":"Cancer Discov"},{"key":"2022060623485312800_bib14","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1158\/1078-0432.CCR-10-2372","article-title":"Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma","volume":"17","author":"Ma","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2022060623485312800_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pharmthera.2011.03.009","article-title":"Targeting autophagy during cancer therapy to improve clinical outcomes","volume":"131","author":"Levy","year":"2011","journal-title":"Pharmacol Ther"},{"key":"2022060623485312800_bib16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/auto.19496","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy","volume":"8","author":"Klionsky","year":"2012","journal-title":"Autophagy"},{"key":"2022060623485312800_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11060-011-0684-4","article-title":"Modulation of pediatric brain tumor autophagy and chemosensitivity","volume":"106","author":"Levy","year":"2012","journal-title":"J Neurooncol"},{"key":"2022060623485312800_bib18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF00280130","article-title":"Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis","volume":"42","author":"Augustijns","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"2022060623485312800_bib19","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.2012.44.7888","article-title":"Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma","volume":"31","author":"Trunzer","year":"2013","journal-title":"J Clin Oncol"},{"key":"2022060623485312800_bib20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.surneu.2006.08.080","article-title":"Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme","volume":"67","author":"Briceno","year":"2007","journal-title":"Surg Neurol"},{"key":"2022060623485312800_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-144-5-200603070-00008","article-title":"Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial","volume":"144","author":"Sotelo","year":"2006","journal-title":"Ann Intern Med"},{"key":"2022060623485312800_bib22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/1078-0432.CCR-10-2634","article-title":"Principles and current strategies for targeting autophagy for cancer treatment","volume":"17","author":"Amaravadi","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2022060623485312800_bib23","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1172\/JCI70454","article-title":"Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma","volume":"124","author":"Ma","year":"2014","journal-title":"J Clin Invest"},{"key":"2022060623485312800_bib24","article-title":"Safety and Phase 0 Study of vemurafenib, and oral inhibitor of BRAFV600E in Children with Recurrent\/Refractory BRAFV600E-mutant gliomas","author":"Pacific Pediatric Neuro-Oncology Consortium [Internet]"},{"key":"2022060623485312800_bib25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/pbc.24891","article-title":"Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas","volume":"61","author":"Bautista","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"2022060623485312800_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"}],"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/4\/7\/773\/1820503\/773.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/4\/7\/773\/1820503\/773.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T19:49:13Z","timestamp":1654544953000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/4\/7\/773\/4604\/Autophagy-Inhibition-Improves-Chemosensitivity-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,1]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,6]]},"published-print":{"date-parts":[[2014,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-14-0049","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2159-8290.22530797.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22530788","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22530800","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22530806","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22530803","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22530791","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22530794.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22530794","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22530800.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22530791.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22530797","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.c.6546275","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22530803.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.c.6546275.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22530806.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22530788.v1","asserted-by":"object"}]},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,1]]}}}